The global inflation device market is expected to register considerable growth over the forecast period. Major factors prevailing the market growth include increasing adoption of minimally invasive procedures, rising prevalence of chronic diseases such as cardiovascular diseases (CVDs), and limited stringent approval procedures. CVDs are disorders of the heart and blood vessels and include coronary heart disease, cerebrovascular disease, rheumatic heart disease, and other conditions. WHO estimates that four out of five CVD deaths are due to heart attacks and strokes. Cardiovascular diseases are estimated as one of the major causes of mortality across the globe, accounting for more than 17.3 million mortality per year. The number of mortalities by cardiovascular diseases is further estimated to reach 23.6 million by the year 2030.
Furthermore, the report analyzes the market on the basis of display type, application, end-user, and region. On the basis of display type, the market is divided into analog inflation devices and digital inflation devices. On the basis of application, the market is segmented into interventional radiology, interventional cardiology, urological procedures, gastroenterological procedures, and others. Interventional cardiology application segment is expected to contribute significantly towards market growth. The growth of the segment is backed by the significant prevalence of CVDs across the globe. According to the American Heart Society, in 2017, cardiovascular disease is the cause of around 800 thousand mortality in the US. Moreover, heart diseases are the leading cause of mortality across the globe and the US, and about 370,000 Americans lose their lives every year. Further, as per the American Heart Society, CVDs claim more lives each year than all forms of cancer and Chronic Lower Respiratory Disease altogether in the US. The prevalence of CVDs is further estimated to increase which is a major target indication for interventional cardiology procedures. These procedures utilize inflation devices to inflate and deflate the balloon, thereby augmenting their demand across the globe.
Geographically, the market is segmented into North America, Europe, Asia-Pacific, and Rest of the World. North America is expected to contribute significantly towards the market growth of the forecast period. Increasing prevalence of CVDs coupled with a rising number of minimally invasive surgical procedures and well-developed healthcare infrastructure in the region is expected to fuel the market growth over the forecast period. Europe and Asia-Pacific are expected to register significant growth rate over the forecast period. Furthermore, the market is characterized by the presence of several players that are operating across the globe. Some of the players in the global inflation device market include Boston Scientific Corp., Medtronic PLC, Olympus Corp., B. Braun Melsungen AG, Becton, Dickinson & Co., Merit Medical Systems Inc., and Acclarent, Inc.
Research Methodology:
The market study of the global inflation device market is incorporated by extensive primary and secondary research conducted by a research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.
Secondary Sources Include:
The report is intended for market research firms, investment companies, pharmaceutical & biopharmaceutical companies, research institutes for overall market analysis and competitive analysis. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.
Market Segmentation:
The Report Covers:
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. B. Braun Melsungen AG
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. Swot Analysis
3.3.1.4. Recent Developments
3.3.2. Becton, Dickinson & Co.
3.3.2.1. Overview
3.3.2.2. Financial Analysis
3.3.2.3. Swot Analysis
3.3.2.4. Recent Developments
3.3.3. Boston Scientific Corp.
3.3.3.1. Overview
3.3.3.2. Financial Analysis
3.3.3.3. Swot Analysis
3.3.3.4. Recent Developments
3.3.4. Medtronic PLC
3.3.4.1. Overview
3.3.4.2. Financial Analysis
3.3.4.3. Swot Analysis
3.3.4.4. Recent Developments
3.3.5. Olympus Corp.
3.3.5.1. Overview
3.3.5.2. Financial Analysis
3.3.5.3. Swot Analysis
3.3.5.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global Inflation Device Market by Display Type
5.1.1. Analog Inflation Devices
5.1.2. Display Inflation Devices
5.2. Global Inflation Device Market by Application
5.2.1. Interventional Radiology
5.2.2. Interventional Cardiology
5.2.3. Urological Procedures
5.2.4. Gastroenterological Procedures
5.2.5. Others (Peripheral Vascular Procedures)
5.3. Global Inflation Device Market by End-User
5.3.1. Hospitals and Clinics
5.3.2. Ambulatory Surgery Centers (ASCs)
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. Acclarent, Inc.
7.2. Advanced Lifesciences Pvt. Ltd.
7.3. Atrion Corp.
7.4. B. Braun Melsungen AG
7.5. Becton, Dickinson & Co.
7.6. Boston Scientific Corp.
7.7. Cardinal Health, Inc.
7.8. Conmed Corp.
7.9. Cook Group Inc.
7.10. Medtronic PLC
7.11. Merit Medical Systems Inc.
7.12. Obalon Therapeutics Inc.
7.13. Olympus Corp.
7.14. Teleflex Inc.
7.15. Terumo Medical Corp.
7.16. US Endovascular